![David Kabakoff](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
David Kabakoff
Chairman at
NEXTCURE, INC.
Net worth: 33 139 $ as of 31/08/2026
Profile
Dr. David S.
Kabakoff is a Chairman at NextCure, Inc., a Founding Senior Partner at Healthquest Capital Management Co LLC and an Executive Advisor at Sofinnova Investments, Inc. He is on the Board of Directors at Rainier Therapeutics, Inc., Antiva Biosciences, Inc., Biotheranostics, Inc., Dauntless 1, Inc., Dauntless 2, Inc., Dauntless Pharmaceuticals, Inc., Intrepida Bio, Inc., Neurana Pharmaceuticals, Inc. and RareCyte, Inc.
Dr. Kabakoff was previously employed as an Independent Director by Castle Biosciences, Inc., a Non-Executive Chairman by Cebix, Inc., a Chairman by Amplimmune, Inc., a Chairman by Trius Therapeutics, Inc., an Independent Director by InterMune, Inc., a Chairman & Chief Executive Officer by Salmedix, Inc., a President & Chief Executive Officer by Strategy Advisors LLC, an Executive Vice President by Dura Pharmaceuticals, Inc., a Chairman & Chief Executive Officer by Corvas International, Inc., a Vice President-Research & Development by Hybritech, Inc., a Board Member by Lineagen, Inc., and a President & Chief Executive Officer by Spiros Development Corp II, Inc. He also served on the board at Principia Biopharma, Inc., Avalon Pharmaceuticals, Inc., Allylix, Inc. and Jewish Community Foundation of San Diego.
He received his undergraduate degree from Case Western Reserve University and a doctorate degree from Yale University.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
NEXTCURE, INC. 0.11% | 18/06/2026 | 5,186 ( 0.11% ) | 33 139 $ | 31/08/2026 |
David Kabakoff active positions
| Companies | Position | Start |
|---|---|---|
| NEXTCURE, INC. | Chairman | 01/12/2015 |
Sofinnova Investments, Inc.
 Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Private Equity Investor | 01/01/2009 |
Intrepida Bio, Inc.
 Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Director/Board Member | - |
Neurana Pharmaceuticals, Inc.
 Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Director/Board Member | - |
Rainier Therapeutics, Inc.
 Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Director/Board Member | 18/09/2018 |
Dauntless 1, Inc.
 Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Director/Board Member | - |
Dauntless 2, Inc.
 Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Director/Board Member | - |
Dauntless Pharmaceuticals, Inc.
 Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Director/Board Member | - |
Biotheranostics, Inc.
 Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Director/Board Member | - |
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Former positions of David Kabakoff
| Companies | Position | End |
|---|---|---|
| ░░░░░░ ░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░░░░ ░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░ | ░░░░░░░░░░ |
| ░░░░░░ ░░░░░░░░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
Training of David Kabakoff
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
73
1st degree connections
30
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 30 |
|---|---|
Dura Pharmaceuticals, Inc.
 Dura Pharmaceuticals, Inc. BiotechnologyHealth Technology Develops and markets prescription pharmaceutical products | Health Technology |
Corvas International, Inc.
 Corvas International, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutic agents for cardiovascular, cancer, and other diseases | Health Technology |
Spiros Development Corp II, Inc.
 Spiros Development Corp II, Inc. Pharmaceuticals: MajorHealth Technology Develops a dry powder pulmonary drug delivery system | Health Technology |
Hybritech, Inc.
 Hybritech, Inc. Miscellaneous Commercial ServicesCommercial Services Provides prostate diagnostic testing services | Commercial Services |
InterMune, Inc.
 InterMune, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biotechnology company that researches and develops therapies in pulmonology & orphan fibrotic diseases | Health Technology |
Biotheranostics, Inc.
Biotheranostics, Inc. Medical/Nursing ServicesHealth Services Discovers, develops and commercializes molecular diagnostic tests for cancer patients | Health Services |
Salmedix, Inc.
 Salmedix, Inc. Pharmaceuticals: MajorHealth Technology Develops oncology and small molecule drugs to treat hematologic malignancies | Health Technology |
Allylix, Inc.
 Allylix, Inc. Pharmaceuticals: OtherHealth Technology Develops terpene products and their derivatives | Health Technology |
Amplimmune, Inc.
 Amplimmune, Inc. BiotechnologyHealth Technology Develops immune-based biological treatments | Health Technology |
Lineagen, Inc.
 Lineagen, Inc. Medical/Nursing ServicesHealth Services Provides diagnostic evaluation services | Health Services |
Cebix, Inc.
 Cebix, Inc. Pharmaceuticals: MajorHealth Technology Develops treatments for complications of diabetes | Health Technology |
Castle Biosciences, Inc.
 Castle Biosciences, Inc. Medical SpecialtiesHealth Technology Operates dermatological cancer company which provides clinically actionable genomic information to make accurate treatment decisions | Health Technology |
Principia Biopharma, Inc.
 Principia Biopharma, Inc. Pharmaceuticals: MajorHealth Technology Operates as a R&D driven and AI-powered biopharma company | Health Technology |
Antiva Biosciences, Inc.
 Antiva Biosciences, Inc. Pharmaceuticals: MajorHealth Technology Develops antiviral therapeutics | Health Technology |
Sofinnova Investments, Inc.
Sofinnova Investments, Inc. Investment ManagersFinance Sofinnova Investment invests in companies located in the United States and Europe. The firm targets companies operating in the fields of health technology services and life science. It participates in early and later stage capital requirements. | Finance |
Case Western Reserve University
 Case Western Reserve University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Yale University
 Yale University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Avalon Pharmaceuticals, Inc.
 Avalon Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops therapeutics products | Health Technology |
Trius Therapeutics, Inc.
 Trius Therapeutics, Inc. Pharmaceuticals: MajorHealth Technology Develops antibacterial drugs for the treatment of infections | Health Technology |
Strategy Advisors LLC
 Strategy Advisors LLC Miscellaneous Commercial ServicesCommercial Services Provides strategic advisory services | Commercial Services |
Jewish Community Foundation of San Diego
 Jewish Community Foundation of San Diego Investment Trusts/Mutual FundsMiscellaneous Supports Jewish communities | Miscellaneous |
RareCyte, Inc.
 RareCyte, Inc. Medical SpecialtiesHealth Technology Develops life science research and diagnostic | Health Technology |
Rainier Therapeutics, Inc.
Rainier Therapeutics, Inc. BiotechnologyHealth Technology Operates as clinical stage biotechnology company developing a targeted biologic for the potential treatment of both early stage and metastatic bladder cancer | Health Technology |
Healthquest Capital Management Co LLC
 Healthquest Capital Management Co LLC Investment ManagersFinance HealthQuest Capital invests in companies located in the United States. The firm focuses on services, healthcare IT, medical devices, diagnostics and pharma services. It participates in growth stage transactions with an investment size of USD 20 - 100 million. The firm also makes co-investments and acts as a lead investor. | Finance |
Dauntless 1, Inc.
Dauntless 1, Inc. Pharmaceuticals: MajorHealth Technology Manufactures pharmaceutical products | Health Technology |
Dauntless Pharmaceuticals, Inc.
Dauntless Pharmaceuticals, Inc. Drugstore ChainsRetail Trade Develops specialty drugs | Retail Trade |
NextCure, Inc.
 NextCure, Inc. Pharmaceuticals: MajorHealth Technology Operates as a biopharmaceutical company which discovers and develops novel immuno medicines to treat cancer & immune related diseases | Health Technology |
Dauntless 2, Inc.
Dauntless 2, Inc. Pharmaceuticals: MajorHealth Technology Manufactures and sells pharmaceutical preparations | Health Technology |
Neurana Pharmaceuticals, Inc.
Neurana Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Develops drugs for muscle spasms | Health Technology |
Intrepida Bio, Inc.
Intrepida Bio, Inc. Pharmaceuticals: MajorHealth Technology Manufactures medicines that modulates innate immune system to fight cancer | Health Technology |
- Stock Market
- Insiders
- David Kabakoff
